Site-specific action of l -3,4-dihydroxyphenylalanine in the striatum but not globus pallidus and substantia nigra pars reticulata evokes dyskinetic movements in chronic l -3,4-dihydroxyphenylalanine-treated 6-hydroxydopamine-lesioned rats

Abstract Dyskinesia eventually develops in the majority of Parkinson's disease patients treated with l -3,4-dihydroxyphenylalanine ( l -DOPA). We have investigated the effect of an acute and local administration of l -DOPA, GABA and glutamate to provoke dyskinetic movements in three basal gangl...

Full description

Saved in:
Bibliographic Details
Published inNeuroscience Vol. 166; no. 2; pp. 355 - 358
Main Authors Buck, K, Voehringer, P, Ferger, B
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ltd 17.03.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…